Skip to main content

Find Clinical Trials

Home
Conditions
Immunotherapy

Clinical trial condition

Immunotherapy

Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.

216 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Immunotherapy trial results

Not Yet Recruiting

Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors

NCT07191405

Conditions: Chemotherapy, Immunotherapy
Locations: Not specified

View Trial Details

Not Yet Recruiting

Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment

NCT07168668

Conditions: HCC, Immunotherapy, TACE
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lymphocyte Function Testing in Immuno-oncology

NCT07155811

Conditions: Advanced Solid Tumor Malignancies, Immunotherapy
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

NCT07131501

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

NCT07128251

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

NCT07118566

Conditions: Body Temperature Changes, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

NCT07110662

Conditions: Chemically-Induced Disorders, Cutaneous Adverse Drug Reactions (CADR), Dermatitis, +17 more
Locations: Reference Center for Toxic, Toxin and Toxidermal Bullous Dermatoses - E. Herriot Hospital Lyon, France

View Trial Details

Not Yet Recruiting

Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)

NCT06711770

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: CHU de Bordeaux, service d'Oncologie Médicale Bordeaux, France

View Trial Details

Not Yet Recruiting

A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC

NCT07086326

Conditions: AK112, Bispecific Antibody, Immunotherapy, +2 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Hunan Cancer Hospital Changsha, Hunan, China

Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

The First Affiliated Hospital of Xi'an Jiaotong University Xi’an, Shanxi, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

NCT07070713

Conditions: Immunotherapy, Metastatic Colorectal Cancer With Left-sided Primary Tumor
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

View Trial Details